BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31887606)

  • 1. Resting-state connectivity and the effects of treatment in restless legs syndrome.
    Lee YS; Ku J; Kim KT; Chang H; Earley CJ; Allen RP; Cho YW
    Sleep Med; 2020 Mar; 67():33-38. PubMed ID: 31887606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional connectivity alternation of the thalamus in restless legs syndrome patients during the asymptomatic period: a resting-state connectivity study using functional magnetic resonance imaging.
    Ku J; Cho YW; Lee YS; Moon HJ; Chang H; Earley CJ; Allen RP
    Sleep Med; 2014 Mar; 15(3):289-94. PubMed ID: 24555993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the changed hubs and corresponding functional connectivity in idiopathic restless legs syndrome.
    Liu C; Wang J; Hou Y; Qi Z; Wang L; Zhan S; Wang R; Wang Y
    Sleep Med; 2018 May; 45():132-139. PubMed ID: 29680421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Default mode network disturbances in restless legs syndrome/Willis-Ekbom disease.
    Ku J; Lee YS; Chang H; Earley CJ; Allen RP; Cho YW
    Sleep Med; 2016 Jul; 23():6-11. PubMed ID: 27692278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diurnal variation of default mode network in patients with restless legs syndrome.
    Ku J; Lee YS; Chang HW; Earley CJ; Allen RP; Cho YW
    Sleep Med; 2018 Jan; 41():1-8. PubMed ID: 29425573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined resting state functional magnetic resonance imaging and diffusion tensor imaging study in patients with idiopathic restless legs syndrome.
    Zhuo Y; Wu Y; Xu Y; Lu L; Li T; Wang X; Li K
    Sleep Med; 2017 Oct; 38():96-103. PubMed ID: 29031764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of increased intrinsic functional connectivity in patients with restless legs syndrome are associated with attentional control of sensory inputs.
    Gorges M; Rosskopf J; Müller HP; Lindemann K; Hornyak M; Kassubek J
    Neurosci Lett; 2016 Mar; 617():264-9. PubMed ID: 26921454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in Salience Network Functional Connectivity in Individuals with Restless Legs Syndrome.
    Ku J; Lee YS; Kim KT; Chang H; Cho YW
    Sci Rep; 2020 May; 10(1):7643. PubMed ID: 32377013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping intrinsic functional brain changes and repetitive transcranial magnetic stimulation neuromodulation in idiopathic restless legs syndrome: a resting-state functional magnetic resonance imaging study.
    Liu C; Dai Z; Zhang R; Zhang M; Hou Y; Qi Z; Huang Z; Lin Y; Zhan S; He Y; Wang Y
    Sleep Med; 2015 Jun; 16(6):785-91. PubMed ID: 25959094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered cortical gray matter volume and functional connectivity after transcutaneous spinal cord direct current stimulation in idiopathic restless legs syndrome.
    Wang L; Liu C; Hou Y; Zhan S; Zhang Z; Wang J; Wang Y
    Sleep Med; 2020 Oct; 74():254-261. PubMed ID: 32862009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and functional multilayer network analysis in restless legs syndrome patients.
    Park KM; Kim KT; Lee DA; Motamedi GK; Cho YW
    J Sleep Res; 2024 May; 33(3):e14104. PubMed ID: 37963544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic dopaminergic treatment in restless legs syndrome: does it affect the autonomic nervous system?
    Rocchi C; Albanese M; Placidi F; Romigi A; Lauretti B; Marfia GA; Liguori C; Marciani MG; Mercuri NB; Izzi F
    Sleep Med; 2015 Sep; 16(9):1071-6. PubMed ID: 26298781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacies of oral iron and pramipexole for the treatment of restless legs syndrome patients with low serum ferritin.
    Lee CS; Lee SD; Kang SH; Park HY; Yoon IY
    Eur J Neurol; 2014 Feb; 21(2):260-6. PubMed ID: 24267148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation in patients with restless legs syndrome receiving pramipexole therapy: a retrospective study in a single center from China.
    Wang T; Ying M; Zhao R; Zhu D; Zhang L
    Sleep Breath; 2022 Mar; 26(1):373-380. PubMed ID: 33864178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of pramipexole for patients with restless legs syndrome (RLS) and RLS-related impairment of mood.
    Montagna P; Hornyak M; Ulfberg J; Hong SB; Koester J; Crespi G; Albrecht S
    Sleep Med; 2011 Jan; 12(1):34-40. PubMed ID: 20965780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of Restless legs syndrome in patients with Parkinson's disease.
    Nomura T; Inoue Y; Nakashima K
    J Neurol Sci; 2006 Dec; 250(1-2):39-44. PubMed ID: 16899256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in pain responses in treated and untreated patients with restless legs syndrome: associations with sleep disruption.
    Edwards RR; Quartana PJ; Allen RP; Greenbaum S; Earley CJ; Smith MT
    Sleep Med; 2011 Jun; 12(6):603-9. PubMed ID: 21570347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive function in patients with idiopathic Restless Legs Syndrome before and after treatment with dopamine-agonist.
    Galbiati A; Marelli S; Giora E; Zucconi M; Oldani A; Ferini-Strambi L
    Int J Psychophysiol; 2015 Mar; 95(3):304-9. PubMed ID: 25514234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High national rates of high-dose dopamine agonist prescribing for restless legs syndrome.
    Winkelman JW
    Sleep; 2022 Feb; 45(2):. PubMed ID: 34417810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional connectivity and topology in patients with restless legs syndrome: a case-control resting-state functional magnetic resonance imaging study.
    Tuovinen N; Stefani A; Mitterling T; Heidbreder A; Frauscher B; Gizewski ER; Poewe W; Högl B; Scherfler C
    Eur J Neurol; 2021 Feb; 28(2):448-458. PubMed ID: 33032390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.